vs
Aurinia Pharmaceuticals Inc.（AUPH）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
Aurinia Pharmaceuticals Inc.的季度营收约是READING INTERNATIONAL INC的1.5倍（$77.1M vs $50.3M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs -5.1%，领先278.5%），Aurinia Pharmaceuticals Inc.同比增速更快（28.8% vs -14.2%），过去两年Aurinia Pharmaceuticals Inc.的营收复合增速更高（23.8% vs 5.6%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
AUPH vs RDI — 直观对比
营收规模更大
AUPH
是对方的1.5倍
$50.3M
营收增速更快
AUPH
高出43.0%
-14.2%
净利率更高
AUPH
高出278.5%
-5.1%
两年增速更快
AUPH
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $50.3M |
| 净利润 | $210.8M | $-2.6M |
| 毛利率 | 88.6% | — |
| 营业利润率 | 43.1% | -1.9% |
| 净利率 | 273.4% | -5.1% |
| 营收同比 | 28.8% | -14.2% |
| 净利润同比 | 14651.2% | -14.5% |
| 每股收益（稀释后） | $1.52 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRDI
| Q4 25 | $77.1M | $50.3M | ||
| Q3 25 | $73.5M | $52.2M | ||
| Q2 25 | $70.0M | $60.4M | ||
| Q1 25 | $62.5M | $40.2M | ||
| Q4 24 | $59.9M | $58.6M | ||
| Q3 24 | $67.8M | $60.1M | ||
| Q2 24 | $57.2M | $46.8M | ||
| Q1 24 | $50.3M | $45.1M |
净利润AUPHRDI
| Q4 25 | $210.8M | $-2.6M | ||
| Q3 25 | $31.6M | $-4.2M | ||
| Q2 25 | $21.5M | $-2.7M | ||
| Q1 25 | $23.3M | $-4.8M | ||
| Q4 24 | $1.4M | $-2.2M | ||
| Q3 24 | $14.3M | $-7.0M | ||
| Q2 24 | $722.0K | $-12.8M | ||
| Q1 24 | $-10.7M | $-13.2M |
毛利率AUPHRDI
| Q4 25 | 88.6% | — | ||
| Q3 25 | 88.9% | — | ||
| Q2 25 | 89.8% | — | ||
| Q1 25 | 86.3% | — | ||
| Q4 24 | 90.7% | — | ||
| Q3 24 | 91.1% | — | ||
| Q2 24 | 84.4% | — | ||
| Q1 24 | 84.6% | — |
营业利润率AUPHRDI
| Q4 25 | 43.1% | -1.9% | ||
| Q3 25 | 40.5% | -0.6% | ||
| Q2 25 | 28.7% | 4.8% | ||
| Q1 25 | 35.0% | -17.2% | ||
| Q4 24 | -2.8% | 2.6% | ||
| Q3 24 | 17.3% | -0.6% | ||
| Q2 24 | -2.6% | -16.4% | ||
| Q1 24 | -26.3% | -16.7% |
净利率AUPHRDI
| Q4 25 | 273.4% | -5.1% | ||
| Q3 25 | 42.9% | -8.0% | ||
| Q2 25 | 30.7% | -4.4% | ||
| Q1 25 | 37.4% | -11.8% | ||
| Q4 24 | 2.4% | -3.8% | ||
| Q3 24 | 21.2% | -11.7% | ||
| Q2 24 | 1.3% | -27.4% | ||
| Q1 24 | -21.4% | -29.4% |
每股收益（稀释后）AUPHRDI
| Q4 25 | $1.52 | $-0.11 | ||
| Q3 25 | $0.23 | $-0.18 | ||
| Q2 25 | $0.16 | $-0.12 | ||
| Q1 25 | $0.16 | $-0.21 | ||
| Q4 24 | $0.00 | $-0.11 | ||
| Q3 24 | $0.10 | $-0.31 | ||
| Q2 24 | $0.01 | $-0.57 | ||
| Q1 24 | $-0.07 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $581.3M | $-18.2M |
| 总资产 | $751.6M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AUPHRDI
| Q4 25 | $80.2M | $10.5M | ||
| Q3 25 | $72.9M | $8.1M | ||
| Q2 25 | $52.9M | $9.1M | ||
| Q1 25 | $66.1M | $5.9M | ||
| Q4 24 | $83.4M | $12.4M | ||
| Q3 24 | $36.6M | $10.1M | ||
| Q2 24 | $33.3M | $9.3M | ||
| Q1 24 | $63.9M | $7.5M |
总债务AUPHRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AUPHRDI
| Q4 25 | $581.3M | $-18.2M | ||
| Q3 25 | $365.8M | $-12.1M | ||
| Q2 25 | $335.3M | $-7.7M | ||
| Q1 25 | $350.2M | $-8.1M | ||
| Q4 24 | $377.5M | $-4.4M | ||
| Q3 24 | $388.0M | $1.6M | ||
| Q2 24 | $364.6M | $6.5M | ||
| Q1 24 | $359.5M | $18.0M |
总资产AUPHRDI
| Q4 25 | $751.6M | $434.9M | ||
| Q3 25 | $527.5M | $435.2M | ||
| Q2 25 | $502.6M | $438.1M | ||
| Q1 25 | $504.9M | $441.0M | ||
| Q4 24 | $550.6M | $471.0M | ||
| Q3 24 | $549.4M | $495.7M | ||
| Q2 24 | $523.5M | $494.9M | ||
| Q1 24 | $516.6M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流AUPHRDI
| Q4 25 | $45.7M | $4.3M | ||
| Q3 25 | $44.4M | $295.0K | ||
| Q2 25 | $44.2M | $1.6M | ||
| Q1 25 | $1.3M | $-7.7M | ||
| Q4 24 | $30.1M | $8.0M | ||
| Q3 24 | $17.0M | $1.3M | ||
| Q2 24 | $15.8M | $-10.4M | ||
| Q1 24 | $-18.6M | $-2.8M |
自由现金流AUPHRDI
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | — | $-4.7M |
自由现金流率AUPHRDI
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | — | -22.7% | ||
| Q1 24 | — | -10.4% |
资本支出强度AUPHRDI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 4.3% |
现金转化率AUPHRDI
| Q4 25 | 0.22× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 21.07× | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 21.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
